US equities
|
NVDA
$233.95
▲+1.34%
MU
$1,074.89
▼-2.05%
TSLA
$370.59
▲+4.65%
SPCX
$158.96
▲+7.35%
SNDK
$1,719.99
▼-3.79%
AMD
$633.91
▲+2.95%
STX
$848.99
▼-10.21%
INTC
$119.33
▼-0.56%
NVDA
$233.95
▲+1.34%
MU
$1,074.89
▼-2.05%
TSLA
$370.59
▲+4.65%
SPCX
$158.96
▲+7.35%
SNDK
$1,719.99
▼-3.79%
AMD
$633.91
▲+2.95%
STX
$848.99
▼-10.21%
INTC
$119.33
▼-0.56%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Intellia Therapeutics, Inc. - Common Stock
(NQ:
NTLA
)
12.26
+0.14 (+1.16%)
Delayed Quote
Updated: 4:00 PM EDT, Oct 2, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Intellia Therapeutics, Inc. - Common Stock
< Previous
1
2
...
5
6
7
8
9
10
11
12
13
...
21
22
Next >
Cathie Wood-Led Ark Invest Buys $9.9M Worth Of Amazon Shares, Also Picks Up Reddit Stock
↗
June 06, 2024
Via
Benzinga
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
↗
June 06, 2024
The widely followed growth investor made big moves as May came to a close.
Via
The Motley Fool
The 3 Best Biotech Stocks to Buy in June 2024
↗
June 05, 2024
Explore the best biotech stocks to buy in June 2024, with insights on Protagonist, BridgeBio and Intellia.
Via
InvestorPlace
Cracking The Code: Understanding Analyst Reviews For Intellia Therapeutics
↗
June 04, 2024
Via
Benzinga
Cathie Wood Is Buying the Dip on These 2 Biotech Stocks. Should You?
↗
June 04, 2024
In keeping with Cathie Wood's style, these picks are riskier than average.
Via
The Motley Fool
Why Intellia Therapeutics, Inc. Outpaced the Stock Market
↗
May 05, 2024
Investors will be eagerly watching for the performance of Intellia Therapeutics, Inc. in its upcoming earnings disclosure.
Via
Talk Markets
2 Stocks Down 30% to Buy Right Now
↗
April 14, 2024
These stocks have plenty of catalysts ahead.
Via
The Motley Fool
Is Intellia Therapeutics Stock a Buy Now?
↗
March 09, 2024
The company's future will depend on its innovative qualities.
Via
The Motley Fool
Why Intellia Therapeutics Shares Are Trading Higher Monday
↗
June 03, 2024
Intellia's NTLA-2002 is an experimental CRISPR based gene-editing therapy being developed as a one-time treatment for hereditary angioedema (HAE). The company announced the single does treatment led to...
Via
Benzinga
Stericycle, MarineMax, Agios Pharmaceuticals And Other Big Stocks Moving Higher On Monday
↗
June 03, 2024
Via
Benzinga
Cathie Wood-Led Ark Invest Sells Nearly $28M Worth Of Robinhood Shares Amid Crypto API Launch And Lackluster Bitcoin Price Action
↗
May 30, 2024
On Thursday, Cathie Wood-led Ark Invest made notable adjustments to its portfolio, including a significant sell-off of Robinhood Markets Inc (NASDAQ:HOOD) shares.
Via
Benzinga
Cathie Wood's Ark Innovation ETF Sees Sharp Decline Among Top Holdings — Here Are 10-Largest Losers Within ARKF
↗
May 28, 2024
Cathie Wood's flagship ARK Innovation ETF has been navigating through significant losses, showcasing the challenges faced by some of its major holdings.
Via
Benzinga
Topics
ETFs
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
↗
May 22, 2024
The popular growth investor keeps adding to some of her favorite falling stocks.
Via
The Motley Fool
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
↗
May 10, 2024
The popular growth investor bought into one of Thursday's biggest losers and two stocks that have fallen sharply over the past year.
Via
The Motley Fool
NTLA Stock Earnings: Intellia Therapeutics Beats EPS, Beats Revenue for Q1 2024
↗
May 09, 2024
NTLA stock results show that Intellia Therapeutics beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
Via
InvestorPlace
Just Say No to Drugs: 3 Pharma Stocks to Avoid
↗
May 08, 2024
Discover which pharma stocks to avoid in 2023 as we delve into market trends, financial struggles, and the impact on investor portfolios.
Via
InvestorPlace
Shhh! 3 Secret Gene Editing Stocks Flying Below Wall Street’s Radar
↗
May 03, 2024
The gene editing stocks are worth tuning into as some investors out there discount their innovative, albeit early-stage pipelines.
Via
InvestorPlace
3 Gene Editing Stocks with the Potential to Make You an Overnight Millionaire
↗
May 02, 2024
Pay close attention to gene editing stocks. By 2028, according to MarketsandMarkets, the market could be worth about $10.6 billion.
Via
InvestorPlace
Cathie Wood Goes Bargain Hunting. 2 Stocks She Bought This Week.
↗
April 12, 2024
These two stocks could be ripe for a rebound.
Via
The Motley Fool
Bull Market and Beyond: 3 Stocks Just Waiting to Soar
↗
April 09, 2024
These stocks, a bargain today, are players to hold on to for the long term.
Via
The Motley Fool
Kuehn Law Encourages Investors of Intellia Therapeutics, Inc. to Contact Law Firm
April 02, 2024
--News Direct--
Via
News Direct
ARKK’s Tech Bets: Over 500k Roblox Shares Purchased, 1.24M Robinhood Shares Sold
↗
March 29, 2024
Cathie Wood's ARK Innovation ETF had an active trading week, with notable transactions including the purchase of over 500k Roblox shares and the sale of 1.247 million shares of Robinhood Markets.
Via
Talk Markets
Topics
ETFs
Better Cathie Wood Stock: Moderna vs. Intellia
↗
March 28, 2024
Moderna and Intellia have declined in the double digits over the past year.
Via
The Motley Fool
Hot Stocks: The 3 Best Opportunities for Investing in Biotech
↗
March 21, 2024
Biotech stocks can offer some of the best risk vs. reward payoff in the stock market. These three are ones to buy now.
Via
InvestorPlace
3 Stocks That Could Be the Next Big Thing in Gene Editing
↗
March 21, 2024
Gene editing could revolutionize how millions of patients are treated. That could create big opportunities for gene-editing stocks.
Via
InvestorPlace
Intellia Therapeutics Stock Has 119% Upside, According to 1 Wall Street Analyst
↗
March 06, 2024
2024 could see the start of its first late-stage clinical trials.
Via
The Motley Fool
A Bull Market Is Here: 2 Magnificent Stocks Down 80% to Buy Right Now
↗
February 29, 2024
The futures for these two beaten-down stocks could be brighter than their recent pasts.
Via
The Motley Fool
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
↗
February 27, 2024
The popular money manager added to these three existing positions on Monday following disappointing financial updates earlier this month.
Via
The Motley Fool
Cathie Wood's Ark Invest Offloads $6.9M Worth of Coinbase, Robinhood Shares Each Amid Searing Bitcoin Rally — Nvidia Stock Also Shed
↗
February 26, 2024
On Monday, Cathie Wood-led Ark Invest adjusted its portfolio, notably selling shares of cryptocurrency-related companies such as Robinhood Markets Inc (NASDAQ:HOOD) and Coinbase Global Inc (NASDAQ:
Via
Benzinga
Is CRISPR Therapeutics the NVIDIA of gene editing?
February 26, 2024
CRISPR Therapeutics AG (NASDAQ: CRSP) made worldwide headlines when it and partner Vertex Pharmaceuticals Inc. (NASDAQ: VRTX) received the first-ever FDA approv
Via
MarketBeat
Topics
Artificial Intelligence
< Previous
1
2
...
5
6
7
8
9
10
11
12
13
...
21
22
Next >
